CAS#:218949-48-5
Tesamorelin
Size
Research Profile
Tesamorelin
Literature-based research context for laboratory reference only.
Tesamorelin is a stabilized GHRH analogue with a trans-3-hexenoic acid modification conferring resistance to DPP-IV cleavage. Research has focused on its selective GH-releasing properties and effects on visceral adipose tissue reduction.
Selected literature
- Falutz et al., 2010, New England Journal of Medicine.
This page is provided for laboratory reference and literature review only. The material is not presented as a consumer product, medical treatment, diagnostic tool, or recommendation for human or animal use.
Overview
Tesamorelin is presented here as a laboratory reference entry. The Research Profile summarizes literature-based biological context, while this Overview documents the identity record, specification set, preparation format, and quality-reference information available on the page.
The identity block lists CAS number 218949-48-5, molecular formula C₂₂₁H₃₆₆N₇₂O₆₇S, and molecular weight 5,135.8 Da. The material record is paired with ≥99% purity information and a lyophilized presentation for reference review.
Available specification labels include 2mg, 5mg, and 10mg. The active selection is 2mg; changing the selector updates the visible specification label and COA lot references while preserving the same research-reference context.
For the active selection, the page currently shows 1 active COA lot reference. COA links, when present, are retained for batch-level purity, identity, and quantity review, while packaging and storage details remain separated in Structure & Identity.